-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VNujuA4llCEqH+tD+9H4A7wI3jjooNqPJSpXVNcXRvjaVp31VT+5yo38m4EeyTbs NUSOnTU+Phz9uq54/78dMw== 0001209191-04-024128.txt : 20040506 0001209191-04-024128.hdr.sgml : 20040506 20040506125502 ACCESSION NUMBER: 0001209191-04-024128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040505 FILED AS OF DATE: 20040506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195508500 MAIL ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADELMAN BURT A CENTRAL INDEX KEY: 0001226283 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 04784137 BUSINESS ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-05-05 0 0000875045 BIOGEN IDEC INC BIIB 0001226283 ADELMAN BURT A 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 1 0 0 EVP, Development Common Stock 2004-05-05 4 M 0 4200.0000 12.9100 A 69000.0000 D Common Stock 2004-05-05 4 S 0 4200.0000 58.2600 D 64800.0000 D Common Stock 2004-05-05 4 M 0 500.0000 12.9100 A 64800.0000 D Common Stock 2004-05-05 4 S 0 500.0000 58.2800 D 64300.0000 D Common Stock 2004-05-05 4 M 0 2900.0000 12.9100 A 64300.0000 D Common Stock 2004-05-05 4 S 0 2900.0000 58.2900 D 61400.0000 D Common Stock 2004-05-05 4 M 0 1100.0000 12.9100 A 61400.0000 D Common Stock 2004-05-05 4 S 0 1100.0000 58.3100 D 60300.0000 D Common Stock 2004-05-05 4 M 0 1300.0000 12.9100 A 60300.0000 D Common Stock 2004-05-05 4 S 0 1300.0000 58.3000 D 59000.0000 D Common Stock 12269.0000 D Common Stock 8009.0000 I by GRATs Stock Option (right-to-buy) 12.9100 2004-05-05 4 M 0 4200.0000 D 2006-04-18 Common Stock 4200.0000 64800.0000 D Stock Option (right-to-buy) 12.9100 2004-05-05 4 M 0 500.0000 D 2006-04-18 Common Stock 500.0000 64300.0000 D Stock Option (right-to-buy) 12.9100 2004-05-05 4 M 0 2900.0000 D 2006-04-18 Common Stock 2900.0000 61400.0000 D Stock Option (right-to-buy) 12.9100 2004-05-05 4 M 0 1100.0000 D 2006-04-18 Common Stock 1100.0000 60300.0000 D Stock Option (right-to-buy) 12.9100 2004-05-05 4 M 0 1300.0000 D 2006-04-18 Common Stock 1300.0000 59000.0000 D Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16-3(d). The stock option became exercisable in six (6) equal annual installments, commencing one year after the grant date of 04/18/96. By: Benjamin S. Harshbarger For: Burt A. Adelman 2006-05-05 EX-24.4_40987 2 poa.txt POA DOCUMENT POWER OF ATTORNEY I, the undersigned, a director and/or an executive officer of Biogen Idec Inc., hereby authorize and designate Thomas J. Bucknum, Anne Marie Cook, Jo Ann Taormina, and Benjamin S. Harshbarger and each of them acting alone, as my attorney-in-fact to execute and file on my behalf any and all Forms 3, 4 and 5 (including any amendments thereto) that I may be required to file with the United States Securities and Exchange Commission as a result of my ownership of or transactions in securities of Biogen Idec Inc. The authority granted under this power of attorney shall continue for so long as I am required to file Forms 3, 4 and 5 with regard to my ownership of or transactions in securities of Biogen Idec Inc., unless earlier revoked in writing, but shall terminate automatically as to each individual attorney-in-fact when such person is no longer an employee of Biogen Idec Inc. I acknowledge that the attorneys-in-fact appointed hereunder are not assuming, nor is Biogen Idec Inc. assuming, any of my responsibility to comply with Section 16 of the Securities Exchange Act of 1934. IN WITNESS WHEREOF, the undersigned has caused this instrument to be duly executed this 25th day of January, 2004. /s/ Burt A. Adelman Burt A. Adelaman -----END PRIVACY-ENHANCED MESSAGE-----